Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 35 - Antineoplastic agents
Patents for A61P 35 - Antineoplastic agents (221,099)
06/2014
06/18/2014EP2741747A1 JAK P13K/mTOR COMBINATION THERAPY
06/18/2014CN1266421B Anti-cancer compounds
06/18/2014CN103874722A Method for manufacturing block copolymer
06/18/2014CN103874709A Anti-tie2 antibodies uses thereof
06/18/2014CN103874700A Pyrazolo[3,4-c]pyridine compounds and methods of use
06/18/2014CN103874696A Quinazoline derivatives as kinases inhibitors and methods of use thereof
06/18/2014CN103874690A Hydrazide containing nuclear transport modulators and uses thereof
06/18/2014CN103874686A Piperidine derivatives and compositions for the inhibition of nicotinamide phosphoribosyltransferase (nampt)
06/18/2014CN103874511A Brain tumor targeting peptides and methods
06/18/2014CN103874505A Compositions and methods for prevention of escape mutation in the treatment of her2/neu over-expressing tumors
06/18/2014CN103874500A Pharmaceutical composition for preventing and treating complications of diabetes containing a traditional oriental medicine extract or a fraction thereof as an active ingredient
06/18/2014CN103874494A Combination therapies for treating hematologic malignancies using pyridopyrimidinone inhibitors of pi3k/mtor with bendamustine and/or rituximab
06/18/2014CN103866018A MicroRNA-Based Methods and Compositions For the Diagnosis, Prognosis and Treatment of Breast Cancer
06/18/2014CN103866017A MicroRNA-Based Methods and Compositions For the Diagnosis, Prognosis and Treatment of Breast Cancer
06/18/2014CN103866008A Ultraconserved regions encoding ncrnas
06/18/2014CN103865899A Fusion toxin with specificity of VEGFR2/KDR acceptor, and coding gene and application thereof
06/18/2014CN103865878A Monoclonal antibody for antagonistic inhibition of combination of vascular endothelial cell growth factor and receptor thereof, hybridoma cell line secreting monoclonal antibody, and use of monoclonal antibody
06/18/2014CN103865874A CIK cell, and preparation method and application thereof
06/18/2014CN103865809A Novel anti-tumor application of penicillium enol B1 from penicillium citrinum
06/18/2014CN103865808A Novel anti-tumor application of penicillium enol A1 from penicillium citrinum
06/18/2014CN103865807A Novel anti-tumor application of penicillium enol B2 from penicillium citrinum
06/18/2014CN103865069A Active targeting star polymer carrier with physiological environment response function and preparation method thereof
06/18/2014CN103864962A Amino modified cyclodextrin based artemisinin prodrug and its preparation method
06/18/2014CN103864955A Folic acid-glucan conjugate and application thereof
06/18/2014CN103864952A Preparation method and application of micro-molecular glycyrrhiza polysaccharide with anti-tumor activity
06/18/2014CN103864947A Process for separating and extracting angelica polysaccharide and application thereof
06/18/2014CN103864944A Method for preparing pholiota nameko polysaccharide crude products
06/18/2014CN103864939A mGM-CSF/beta hCG fusion protein, and preparation method and application thereof
06/18/2014CN103864938A Target-specificity double-mutant fused protein and preparation process thereof
06/18/2014CN103864936A HPV18 type L2NE7E6 fusion protein gene, and expression vector, preparation method, strain and use thereof
06/18/2014CN103864935A Targeted EGFR/KDR (Epidermal Growth Factor Receptor/Kinase Insert Domain Receptor) specific diabody
06/18/2014CN103864932A Monoclonal antibody for antagonistically inhibiting combination of vascular endothelial growth factor with its receptor, and coding sequence and use thereof
06/18/2014CN103864923A Glycosylated antibodies
06/18/2014CN103864921A Folic acid-adriamycin immunological preparation for treating cancer through dual targets and preparation method thereof
06/18/2014CN103864893A Novel immunogenic epitopes for immunotherapy
06/18/2014CN103864890A Imidazolisopropylacetyltheaninecarbobenzoxypyridoindole, and preparation method, nanostructure and application thereof
06/18/2014CN103864882A Oleanolic acid-pyrimidine conjugate as well as preparation method and application thereof
06/18/2014CN103864881A Oleanolic acid-uridine conjugate as well as preparation method and application thereof
06/18/2014CN103864880A Oleanolic acid-pyrimidine conjugate as well as preparation method and application thereof
06/18/2014CN103864876A Xylogranatumin G and preparation method and application thereof
06/18/2014CN103864874A Phellinus igniarius monomer component ergot ketosteroid and preparation method and application thereof in preparation of anti-tumor drugs
06/18/2014CN103864871A Gemcitabine hydrochloride compound
06/18/2014CN103864854A Dual-core platinum complex having anti-tumor activity and preparation method thereof
06/18/2014CN103864833A Axial end hydroxyl substituted silicon phthalocyanine and self-assembling body thereof
06/18/2014CN103864822A Chiral antipode mononuclear complex as well as preparation method and applications thereof
06/18/2014CN103864811A Novel 10-hydroxy camptothecin site-20 derivative preparation method, and application of 10-hydroxy camptothecin site 20 derivative in anti-tumor drugs
06/18/2014CN103864810A Preparation method of novel 10-hydroxycamptothecine 10-position derivatives and application in antitumor drugs
06/18/2014CN103864803A Preparation of 1-(phenyl)-1, 3, 4, 9-tetrahydropyrano[3, 4-b]indole derivative and application in antitumor drugs
06/18/2014CN103864793A Substituted purin-9-acetamino isohydroxamic acid histone deacetylase inhibitor and preparation method and application thereof
06/18/2014CN103864792A Heterocyclic nitrogen compound acting as tyrosine kinase inhibitor
06/18/2014CN103864788A N<5>,N<10>-methylene-8-deazatetrafolate, and synthetic method and application thereof
06/18/2014CN103864785A Thiazoline derivatives with aza-indole framework as well as preparation method and application thereof
06/18/2014CN103864784A Novel azaindole-2-ketone FGFR1 (Fibroblast Growth Factor Receptor1) inhibitor and anti-tumor activity thereof
06/18/2014CN103864781A Novel 1,9-disubstituted tetrahydrocarboline derivative preparation, and application of 1,9-disubstituted tetrahydrocarboline derivatives in anti-tumor drugs
06/18/2014CN103864780A Preparation of new drug 1H-pyrrolo[2,3-b]pyridine-5-carboxylic acid methyl ester derivatives and application in antitumor drugs
06/18/2014CN103864779A Preparation of 1-(phenyl)-2,3,4,9-tetrahydro-1H-pyridino[3,4-b]indole derivatives and application of derivatives in antitumor drugs
06/18/2014CN103864778A Triethoxy phenanthroquinolizidine salt derivative
06/18/2014CN103864776A Tegafur derivative containing 1,3,4-thiadiazole heterocyclic ring and amide group
06/18/2014CN103864770A Pyrimidinamine and pyridinamine Hedgehog signal conduction inhibitors
06/18/2014CN103864765A Benzoazepine derivative containing five-membered heterocycle as well as preparation method and application of derivative
06/18/2014CN103864764A Indazole-substituted pyrimidinamine derivative, and preparation method and use thereof
06/18/2014CN103864763A Monohydrate Crystalline Form of 3-(5-(4-(3-Fluoropropyl)-Piperazin-1-YL)Benzimidazol-2-YL)-1-Azaazulen-2-One, Preparation, and Pharmaceutical Composition Thereof
06/18/2014CN103864762A 3,6-bis(pyridine-4-ylacetenyl) carbazole derivatives as well as preparation method and application thereof
06/18/2014CN103864750A Derivative of N-biphenyl dichloroacetamide as well as preparation method and applications thereof
06/18/2014CN103864742A Preparation and anti-tumor application of novel naringenin derivatives
06/18/2014CN103864740A Preparation method of gardenia flower flavones with anticancer activity
06/18/2014CN103864738A Phellinus monomer component Phellinus igniarius E and inoscavin A and preparation method thereof as well as application of Phellinus igniarius E and inoscavin A in anticancer drugs
06/18/2014CN103864735A Synthesis of novel 5-bromo-3(2H)-benzofuranone derivatives and application in antitumor drugs
06/18/2014CN103864734A Synthesis and application of novel 4,6-dihydroxy-3(2H)-benzofuranone derivatives
06/18/2014CN103864722A Synthesis and anti-cancer pharmaceutical effects of novel [4-(4-phenoxymethyl)benzoyl]piperazine derivatives
06/18/2014CN103864720A Phenyl acrylic acid farnesyl thiosalicylic acid (FTA) derivative as well as preparation method and application
06/18/2014CN103864687A Dicranostigma leptopodum berberrubine salt derivative
06/18/2014CN103864684A Synthesis of novel 3,4-dihydro-1(2H)isoquinoline derivatives and application in antitumor drugs
06/18/2014CN103864681A Antibacterial chloroxoquinoline derivative
06/18/2014CN103864680A Chloroxoquinoline derivatives with anti-tumor activity
06/18/2014CN103864642A Rheinic acid derivatives, and synthetic method and applications thereof
06/18/2014CN103861127A SPIO-shRNA (superparamagnetic iron oxide-short hair ribonucleic acid) molecular probe with dual actions of MR (magnetic resonance) gene imaging and targeting therapy
06/18/2014CN103861124A Preparation method of platinum nanoclusters and application of platinum nanoclusters in tumor imaging agents and apoptosis agents
06/18/2014CN103861123A Diagnosis-treatment integrated nanometer material, diagnosis-treatment integrated nanometer preparation and preparation method of nanometer preparation
06/18/2014CN103861121A Use of micro-RNA molecule miR491-5p in treatment and/or diagnosis and/or prognosis of pancreatic cancer
06/18/2014CN103861119A Graphene oxide berberine conjugate and preparation method thereof
06/18/2014CN103861118A Preparation method and application of graphene-CpG
06/18/2014CN103861116A Prodrug of antitumor medicament as well as preparation method and application thereof
06/18/2014CN103861115A Hemoglobin nano-particle and preparation method thereof
06/18/2014CN103861113A Paclitaxel antitumor preparation and preparation method thereof
06/18/2014CN103861112A Pharmaceutical composition based on polymer nanoparticle carrier and preparation method thereof
06/18/2014CN103861108A Novel vortex magnetic-domain iron-based nano magnetic hyperthermia medium and application of medium in tumor magnetic hyperthermia
06/18/2014CN103861107A Pharmaceutical composition and uses thereof
06/18/2014CN103861106A Antagonists of IL-6 to raise albumin and/or lower CRP
06/18/2014CN103861104A Phycocyanin-phthalocyanine compound and preparation method and application thereof
06/18/2014CN103861103A Nano particles compounded of up-conversion nano particles and gold nanorods and preparation method and application of nano particles
06/18/2014CN103861102A Anti-CTLA-4 antibody compositions
06/18/2014CN103861099A VACCINE ADJUVANT, VACCINE COMPOSITION AND usage of Antrodia camphorate sporocarp
06/18/2014CN103861088A Stem cell preparation for treating primary liver cancer and preparation method thereof
06/18/2014CN103861079A Traditional Chinese medicine composition with effects of clearing heat, relieving pain and eliminating tumors
06/18/2014CN103861037A Traditional Chinese medicine for treating mastofibroma
06/18/2014CN103861026A Pharmaceutical composition for improvement of human immunity and adjuvant therapy of cancers
06/18/2014CN103861006A Traditional Chinese medicine composition for treating uterine cancer
06/18/2014CN103860960A Capsule for treating breast cancer and preparation method thereof
06/18/2014CN103860956A Traditional Chinese medicine composition for treating cyst
1 ... 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 ... 2211